SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-20-039593
Filing Date
2020-11-27
Accepted
2020-11-27 15:30:12
Documents
7
Period of Report
2021-01-04
Effectiveness Date
2020-11-27

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ea130551-def14a_enzobiochem.htm DEF 14A 569203
2 GRAPHIC image_001.jpg GRAPHIC 5559
3 GRAPHIC image_002.jpg GRAPHIC 3356
4 GRAPHIC image_003.jpg GRAPHIC 2702
5 GRAPHIC image_004.jpg GRAPHIC 3034
6 GRAPHIC proxy_001.jpg GRAPHIC 228755
7 GRAPHIC proxy_002.jpg GRAPHIC 267936
  Complete submission text file 0001213900-20-039593.txt   1275281
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: DEF 14A | Act: 34 | File No.: 001-09974 | Film No.: 201354969
SIC: 8071 Services-Medical Laboratories
Office of Life Sciences